Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC
Background Although evidence exists regarding the efficacy of galcanezumab in treating cluster headaches and other trigeminal autonomic cephalalgias (TACs), data on its effectiveness at lower doses are still lacking. Objective To report the clinical outcomes of Latin American patients treated with g...
Saved in:
Published in | Revista Headache Medicine (Online) Vol. 16; no. 1; pp. 65 - 70 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
30.03.2025
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!